2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Withdrawn
1
Active not recruiting
1
Sponsor Class
INDUSTRY
7
OTHER
2
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Turcot syndrome
1
Pancreatic Neoplasms
1
Colorectal Neoplasms
1
Interventions
Cyclophosphamide
2067
Radiotherapy
1986
Cisplatin
1855
Carboplatin
1559
Gemcitabine
1454
Paclitaxel
1320
Bevacizumab
1318
pembrolizumab
1236
Docetaxel
1227
Oxaliplatin
1184
Capecitabine
1176
Fluorouracil
1083
Dexamethasone
978
Magnetic Resonance Spectroscopy
969
Nivolumab
936
Rituximab
929
Drug Therapy
914
Surveys and Questionnaires
898
Doxorubicin
845
Etoposide
843
Radiosurgery
815
Blood Specimen Collection
815
Irinotecan
784
Cytarabine
743
fludarabine
726
Leucovorin
684
Surgical Procedures, Operative
639
Lenalidomide
618
Biopsy
594
fludarabine phosphate
569
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
IMM-101
×
Clear all
NCT06498518
2025-07-11
PRIMUS006
University of Glasgow
Phase 2
Withdrawn
NCT05118724
2025-06-15
ANTONIO
AIO-Studien-gGmbH
Phase 2
Active not recruiting
80 enrolled